Page last updated: 2024-08-16

quipazine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

quipazine has been researched along with 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Booij, J; De Bruin, K; Gunning, WB; Lavalaye, J; Reneman, L1

Other Studies

1 other study(ies) available for quipazine and 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane

ArticleYear
Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus.
    Synapse (New York, N.Y.), 2001, Mar-01, Volume: 39, Issue:3

    Topics: Animals; Biogenic Monoamines; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoxetine; Hippocampus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Neurons; Prefrontal Cortex; Quipazine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tropanes

2001